WOCKPHARMAWockhardt Ltd.

₹1393.7-1.75%

Market Cap

₹23,061.70 Cr

Stock P/E

-187.49

ROCE

4.07%

ROE

-1.48%

Book Value

₹260.52

Financials

YoY Net Sales

EPS Growth

Operating Margin

No recent news available for this stock.

Holdings

Distribution

Promoter

Institution

Public

Others

POSITIVES

•
EBITDA growth and margin expansion indicate improving profitability
•
ZAYNICH Phase 3 success demonstrates strong R&D progress and potential in NCE portfolio

NEGATIVES

•
ZAYNICH’s market focus may be limited to hospitals/tertiary care rather than mass-market adoption
•
Past product introductions show execution and learning curves risk in new launches

Peer comparison data is not available for this stock.